The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol
Calogero Longhitano(Queensland Health), Zóltan Sarnyai(Australian Institute of Tropical Health and Medicine), Mostafa Rahimi Azghadi(James Cook University), Flávia Fayet‐Moore(The University of Sydney), Sabine Finlay(Australian Institute of Tropical Health and Medicine), Donna Rudd(James Cook University), Iain H. Campbell(Royal Edinburgh Hospital), Gideon Vos(Australian Institute of Tropical Health and Medicine), Isabella Peachey(Australian Institute of Tropical Health and Medicine), Toby Bartle(Australian Institute of Tropical Health and Medicine), Omer Shareef(Queensland Health), Shaileigh Gordon(Queensland Health), Christopher Palmer(Apple (Israel)), Jaymee-Leigh Swift(Mater Health Services), Shebani Sethi(Stanford Health Care)
Cited by 27
Related Papers
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|522
Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
|Psychiatry Research|2024|129
Computer Vision and Deep Learning for Fish Classification in Underwater Habitats: A Survey
|arXiv (Cornell University)|2022|119
Ketogenic diet as a metabolic treatment for mental illness
|Current Opinion in Endocrinology Diabetes and Obesity|2020|82
A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa
|International Journal of Eating Disorders|2019|67